Evoke Pharma (EVOK) Misses Q3 EPS by 45c Nov 13, 2025 07:41AM
Laidlaw Downgrades Evoke Pharma (EVOK) to Hold Nov 6, 2025 09:23AM
QOL Medical to acquire Evoke Pharma for $11 per share in cash Nov 4, 2025 07:03AM
Evoke Pharma expands GIMOTI access through Omnicell partnership Aug 26, 2025 07:22AM
Evoke Pharma patent for GIMOTI nasal spray added to FDA Orange Book Aug 21, 2025 07:01AM


Aug 14, 2025 07:50AM Evoke Pharma (EVOK) Misses Q2 EPS by 62c
Aug 6, 2025 06:31AM Evoke Pharma receives patent extending GIMOTI exclusivity to 2038
Jul 9, 2025 08:17AM Evoke Pharma gets patent approval extending GIMOTI protection to 2036
May 13, 2025 06:19PM Evoke Pharma (EVOK) Misses Q1 EPS by 51c
Mar 13, 2025 04:22PM Evoke Pharma (EVOK) Misses Q4 EPS by 49c
Feb 24, 2025 08:31AM Evoke Pharma (EVOK) Appoints Greg Pyszczymuka to its Board
Nov 8, 2024 06:29AM Evoke Pharma (EVOK) Misses Q3 EPS by 95c
Oct 28, 2024 02:21PM Laidlaw Reiterates Buy Rating on Evoke Pharma (EVOK)
Oct 28, 2024 07:01AM Evoke Pharma (EVOK) and EVERSANA Announce Statistically Significant Improvement in Patient Outcomes for GLP-1 users
Oct 22, 2024 08:31AM Evoke Pharma (EVOK) Appoints Ben Smeal to its Board
Oct 1, 2024 08:30AM Evoke Pharma (EVOK) Receives $3M in Proceeds from Existing Warrants
Sep 19, 2024 02:21PM Evoke Pharma (EVOK) Reaffirms Its Commitment to Patients with Gastroparesis Amid Industry Developments
Aug 13, 2024 08:15AM Evoke Pharma (EVOK) Reports Q2 Loss of $0.93/sh
Jul 30, 2024 08:31AM Evoke Pharma (EVOK) Announces 1:12 Reverse Share Split
Jun 17, 2024 08:31AM Evoke Pharma (EVOK) Reports Commercial Strategy Progress for GIMOTI